These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 16842269)

  • 1. Immunology of canine leishmaniasis.
    Barbiéri CL
    Parasite Immunol; 2006 Jul; 28(7):329-37. PubMed ID: 16842269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
    Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis.
    Reis AB; Giunchetti RC; Carrillo E; Martins-Filho OA; Moreno J
    Trends Parasitol; 2010 Jul; 26(7):341-9. PubMed ID: 20488751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis.
    Chamizo C; Moreno J; Alvar J
    Vet Immunol Immunopathol; 2005 Jan; 103(1-2):67-75. PubMed ID: 15626462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
    Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
    Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine profiles in canine visceral leishmaniasis.
    Carrillo E; Moreno J
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):67-70. PubMed ID: 19054573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T; Anam K; Ali N
    Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis.
    de Lima VM; Ikeda FA; Rossi CN; Feitosa MM; Vasconcelos RO; Nunes CM; Goto H
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):296-302. PubMed ID: 20132994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine expression in dogs with natural Leishmania infantum infection.
    Panaro MA; Brandonisio O; Cianciulli A; Cavallo P; Lacasella V; Paradies P; Testini G; De Caprariis D; Mitolo V; Otranto D
    Parasitology; 2009 Jul; 136(8):823-31. PubMed ID: 19490725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood mononuclear cell supernatants from asymptomatic dogs immunized and experimentally challenged with Leishmania chagasi can stimulate canine macrophages to reduce infection in vitro.
    Rodrigues CA; Batista LF; Teixeira MC; Pereira AM; Santos PO; de Sá Oliveira GG; de Freitas LA; Veras PS
    Vet Parasitol; 2007 Feb; 143(3-4):197-205. PubMed ID: 17045743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Canine leishmaniasis. New concepts of epidemiology and immunopathology: their impact in the control of human visceral leishmaniasis].
    Abranches P; Campino L; Santos-Gomes GM
    Acta Med Port; 1998 Oct; 11(10):871-5. PubMed ID: 10021781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis.
    Fujiwara RT; Vale AM; França da Silva JC; da Costa RT; Quetz Jda S; Martins Filho OA; Reis AB; Corrêa Oliveira R; Machado-Coelho GL; Bueno LL; Bethony JM; Frank G; Nascimento E; Genaro O; Mayrink W; Reed S; Campos-Neto A
    Vet Res; 2005; 36(5-6):827-38. PubMed ID: 16120256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic immune responses during canine visceral leishmaniasis.
    Strauss-Ayali D; Baneth G; Jaffe CL
    Vet Res; 2007; 38(4):547-64. PubMed ID: 17540157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance free plasmid DNA expressing LACK protein leads towards a protective Th1 response against Leishmania infantum infection.
    Ramos I; Alonso A; Peris A; Marcen JM; Abengozar MA; Alcolea PJ; Castillo JA; Larraga V
    Vaccine; 2009 Nov; 27(48):6695-703. PubMed ID: 19747996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 and TNF-alpha production during active canine visceral leishmaniasis.
    de Lima VM; Peiro JR; de Oliveira Vasconcelos R
    Vet Immunol Immunopathol; 2007 Jan; 115(1-2):189-93. PubMed ID: 17097150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ-specific immunity in canine visceral leishmaniasis: analysis of symptomatic and asymptomatic dogs naturally infected with Leishmania chagasi.
    Sanchez MA; Diaz NL; Zerpa O; Negron E; Convit J; Tapia FJ
    Am J Trop Med Hyg; 2004 Jun; 70(6):618-24. PubMed ID: 15211002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.
    Carrillo E; Ahmed S; Goldsmith-Pestana K; Nieto J; Osorio Y; Travi B; Moreno J; McMahon-Pratt D
    Vaccine; 2007 Feb; 25(8):1534-43. PubMed ID: 17178178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.